Genmab A (GMAB) Other Non Operating Income (2024 - 2026)
Genmab A (GMAB) posted Other Non Operating Income of -$163.0 million for Q1 2026, down 840.91% on a QoQ basis from $22.0 million in Q3 2025, and down 1353.85% year-over-year from $13.0 million in Q1 2025.
Genmab A (GMAB) Other Non Operating Income (2024 - 2026) Analysis & Trends
Genmab A's Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$163.0 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163.00 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Sep 30, 2024 | 129.00 Mn |
| Jun 30, 2024 | -126.00 Mn |
| Mar 31, 2024 | 7.00 Mn |